Pellegrini C - Search Results

1

Approaches for designing and discovering purinergic drugs for gastrointestinal diseases.

Dal Ben D, Antonioli L, Lambertucci C, Spinaci A, Fornai M, D'Antongiovanni V, Pellegrini C, Blandizzi C, Volpini R. Dal Ben D, et al. Among authors: pellegrini c. Expert Opin Drug Discov. 2020 Jun;15(6):687-703. doi: 10.1080/17460441.2020.1743673. Epub 2020 Mar 31. Expert Opin Drug Discov. 2020. PMID: 32228110 Review.

2

The role of purinergic pathways in the pathophysiology of gut diseases: pharmacological modulation and potential therapeutic applications.

Antonioli L, Colucci R, Pellegrini C, Giustarini G, Tuccori M, Blandizzi C, Fornai M. Antonioli L, et al. Among authors: pellegrini c. Pharmacol Ther. 2013 Aug;139(2):157-88. doi: 10.1016/j.pharmthera.2013.04.002. Epub 2013 Apr 13. Pharmacol Ther. 2013. PMID: 23588157 Review.

3

NSAID-induced enteropathy: are the currently available selective COX-2 inhibitors all the same?

Fornai M, Antonioli L, Colucci R, Pellegrini C, Giustarini G, Testai L, Martelli A, Matarangasi A, Natale G, Calderone V, Tuccori M, Scarpignato C, Blandizzi C. Fornai M, et al. Among authors: pellegrini c. J Pharmacol Exp Ther. 2014 Jan;348(1):86-95. doi: 10.1124/jpet.113.207118. Epub 2013 Oct 17. J Pharmacol Exp Ther. 2014. PMID: 24135073

4

Role of the A(2B) receptor-adenosine deaminase complex in colonic dysmotility associated with bowel inflammation in rats.

Antonioli L, Fornai M, Awwad O, Giustarini G, Pellegrini C, Tuccori M, Caputi V, Qesari M, Castagliuolo I, Brun P, Giron MC, Scarpignato C, Blandizzi C, Colucci R. Antonioli L, et al. Among authors: pellegrini c. Br J Pharmacol. 2014 Mar;171(5):1314-29. doi: 10.1111/bph.12539. Br J Pharmacol. 2014. PMID: 24286264 Free PMC article.

5

Involvement of the P2X7 purinergic receptor in colonic motor dysfunction associated with bowel inflammation in rats.

Antonioli L, Giron MC, Colucci R, Pellegrini C, Sacco D, Caputi V, Orso G, Tuccori M, Scarpignato C, Blandizzi C, Fornai M. Antonioli L, et al. Among authors: pellegrini c. PLoS One. 2014 Dec 30;9(12):e116253. doi: 10.1371/journal.pone.0116253. eCollection 2014. PLoS One. 2014. PMID: 25549098 Free PMC article.

6

The AMPK enzyme-complex: from the regulation of cellular energy homeostasis to a possible new molecular target in the management of chronic inflammatory disorders.

Antonioli L, Colucci R, Pellegrini C, Giustarini G, Sacco D, Tirotta E, Caputi V, Marsilio I, Giron MC, Németh ZH, Blandizzi C, Fornai M. Antonioli L, et al. Among authors: pellegrini c. Expert Opin Ther Targets. 2016;20(2):179-91. doi: 10.1517/14728222.2016.1086752. Epub 2015 Sep 28. Expert Opin Ther Targets. 2016. PMID: 26414111 Review.

7

Gastric motor dysfunctions in Parkinson's disease: Current pre-clinical evidence.

Pellegrini C, Antonioli L, Colucci R, Ballabeni V, Barocelli E, Bernardini N, Blandizzi C, Fornai M. Pellegrini C, et al. Parkinsonism Relat Disord. 2015 Dec;21(12):1407-14. doi: 10.1016/j.parkreldis.2015.10.011. Epub 2015 Oct 21. Parkinsonism Relat Disord. 2015. PMID: 26499757 Review.

8

Enteric Dysfunctions in Experimental Parkinson's Disease: Alterations of Excitatory Cholinergic Neurotransmission Regulating Colonic Motility in Rats.

Fornai M, Pellegrini C, Antonioli L, Segnani C, Ippolito C, Barocelli E, Ballabeni V, Vegezzi G, Al Harraq Z, Blandini F, Levandis G, Cerri S, Blandizzi C, Bernardini N, Colucci R. Fornai M, et al. Among authors: pellegrini c. J Pharmacol Exp Ther. 2016 Feb;356(2):434-44. doi: 10.1124/jpet.115.228510. Epub 2015 Nov 18. J Pharmacol Exp Ther. 2016. PMID: 26582732

9

Histochemical Detection of Collagen Fibers by Sirius Red/Fast Green Is More Sensitive than van Gieson or Sirius Red Alone in Normal and Inflamed Rat Colon.

Segnani C, Ippolito C, Antonioli L, Pellegrini C, Blandizzi C, Dolfi A, Bernardini N. Segnani C, et al. Among authors: pellegrini c. PLoS One. 2015 Dec 16;10(12):e0144630. doi: 10.1371/journal.pone.0144630. eCollection 2015. PLoS One. 2015. PMID: 26673752 Free PMC article.

10

Small bowel protection against NSAID-injury in rats: Effect of rifaximin, a poorly absorbed, GI targeted, antibiotic.

Fornai M, Antonioli L, Pellegrini C, Colucci R, Sacco D, Tirotta E, Natale G, Bartalucci A, Flaibani M, Renzulli C, Ghelardi E, Blandizzi C, Scarpignato C. Fornai M, et al. Among authors: pellegrini c. Pharmacol Res. 2016 Feb;104:186-96. doi: 10.1016/j.phrs.2015.12.031. Epub 2015 Dec 30. Pharmacol Res. 2016. PMID: 26747402

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,023 results

Search Page